Tissue-engineered vascular grafts created from human induced pluripotent stem cells

Stem Cells Translational Medicine

Volumn 3, Issue 12, 2014, Pages 1535-1543

  Sundaram, Sumati ^a,b   One, Jennifer ^a   Siewert, Joshua ^b   Teodosescu, Stephan ^c   Zhao, Liping ^b   Dimitrievska, Sashka ^a   Qian, Hong ^b   Huang, Angela H ^a   Niklason, Laura ^a,b  

^a Yale University   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CALIFORNIA POLYTECHNIC STATE UNIVERSITY   (United States)

Author keywords

Blood vessel graft; Induced pluripotent stem cells; Smooth muscle cells; Tissue engineering

Indexed keywords

5' NUCLEOTIDASE; CALPONIN; CD45 ANTIGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 3; ENDOGLIN; FATTY ACID BINDING PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; FIBRONECTIN; GLYCOSAMINOGLYCAN; OCTAMER TRANSCRIPTION FACTOR 4; OSTEOCALCIN; PLATELET DERIVED GROWTH FACTOR; PROTEIN P75; STAGE SPECIFIC EMBRYO ANTIGEN 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR PAX3; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; TRANSGELIN; WNT3A PROTEIN; DIFFERENTIATION ANTIGEN;

ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL GRAFT; CELL DIFFERENTIATION; CELL DOUBLING TIME; CELLULAR PARAMETERS; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PLURIPOTENT STEM CELL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMOOTH MUSCLE FIBER; TELOMERE; TISSUE ENGINEERING; BIOSYNTHESIS; BLOOD VESSEL PROSTHESIS; CELL LINE; CYTOLOGY; EXTRACELLULAR MATRIX; METABOLISM; PROCEDURES;

ANTIGENS, DIFFERENTIATION; BLOOD VESSEL PROSTHESIS; CELL LINE; EXTRACELLULAR MATRIX; HUMANS; INDUCED PLURIPOTENT STEM CELLS; TISSUE ENGINEERING;

EID: 84913531122     PISSN: 21576564     EISSN: 21576580     Source Type: Journal    
DOI: 10.5966/sctm.2014-0065     Document Type: Article

References (43)

1. Roger VL, Go AS, Lloyd-Jones DM et al. Heart disease and stroke statistics: 2012 update: A report from the American Heart Association. Circulation 2012;125:e2–e220.
2. Niklason LE, Gao J, Abbott WM et al. Functional arteries grown in vitro. Science 1999;284: 489–493.
3. Syedain ZH, Meier LA, Bjork JW et al. Im-plantable arterial grafts from human fibroblasts and fibrin using a multi-graft pulsed flow-stretch bioreactor with noninvasive strength monitoring. Biomaterials 2011;32:714–722.
4. Gauvin R, Ahsan T, Larouche D et al. Anovel single-step self-assembly approach for the fabrication of tissue-engineered vascular constructs. Tissue Eng Part A 2010;16:1737–1747.
5. Lovett M, Eng G, Kluge JA et al. Tubular silk scaffolds for small diameter vascular grafts. Or-ganogenesis 2010;6:217–224.
6. L’Heureux N, Pâquet S, Labbé R et al. A completely biological tissue-engineered human blood vessel. FASEB J 1998;12:47–56.
7. Isenberg BC, Williams C, Tranquillo RT. Small-diameter artificial arteries engineered in vitro. Circ Res 2006;98:25–35.
8. Niklason L. Cellular lifespan and regenerative medicine. Biomaterials 2007.
9. Quint C, Kondo Y, Manson RJ et al. Decel-lularized tissue-engineered blood vessel as an arterial conduit. Proc Natl Acad Sci USA 2011; 108:9214–9219.
10. Dahl SLM et al. Readily available tissue- engineered vascular grafts. Sci Transl Med 2011; 3:68ra9.
11. Liu JY, Peng HF, Andreadis ST. Contractile smooth muscle cells derived from hair-follicle stem cells. Cardiovasc Res 2008;79:24-33.
12. Ghionzoli M, Repele A, Sartiani L et al. Human amniotic fluid stem cell differentiation along smooth muscle lineage. FASEB J 2013; 27:4853-4865.
13. Wang C, Cen L, Yin S et al. A small diameter elastic blood vessel wall prepared under pulsatile conditions from polyglycolicacid mesh and smooth muscle cells differentiated from adipose-derived stem cells. Biomaterials 2010; 31:621-630.
14. Olivier EN, Bouhassira EE. Differentiation of human embryonic stem cells into mesenchymal stem cells by the “raclure” method. Methods Mol Biol 2011;690:183-193.
15. Cheung C, Bernardo AS, Trotter MWB et al. Generation of human vascular smooth muscle subtypes provides insight into embryo-logical origin-dependent disease susceptibility. Nat Biotechnol 2012;30:165–173.
16. Xie C-Q, Zhang J, Villacorta L et al. A highly efficient method to differentiate smooth muscle cells from human embryonic stem cells. Arterioscler Thromb Vasc Biol 2007;27:e311–e312.
17. Wang A, Tang Z, Li X et al. Derivation of smooth muscle cells with neural crest origin from human induced pluripotent stem cells. Cells Tissues Organs 2012;195:5–14.
18. Bajpai VK, Mistriotis P, Loh Y-H et al. Functional vascular smooth muscle cells derived from human induced pluripotent stem cells via mesenchymal stem cell intermediates. Cardiovasc Res 2012;96:391–400.
19. Menendez L, Kulik MJ, Page AT et al. Directed differentiation of human pluripotent cells to neural crest stem cells. Nat Protoc 2013;8:203–212.
20. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917–1920.
21. Xu C, Inokuma MS, Denham J et al. Feeder-free growth of undifferentiated human embryonic stem cells. Nat Biotechnol 2001;19: 971–974.
22. Johansson BM, Wiles MV. Evidence for involvement of activin A and bone morphoge-netic protein 4 in mammalian mesoderm and hematopoietic development. Mol Cell Biol 1995;15:141–151.
23. Sundaram S, Echter A, Sivarapatna A et al. Small diameter vascular graft engineered using human embryonic stem cell-derived mesenchy-mal cells. Tissue Eng Part A 2013.
24. Cawthon RM. Telomere measurement by quantitative PCR. NucleicAcids Res 2002;30:e47.
25. Quint C, Arief M, Muto A et al. Allogeneic human tissue-engineered blood vessel. J Vasc Surg 2011;55:790–798.
26. Gong Z, Niklason LE. Small-diameter human vessel wall engineered from bone marrow-derived mesenchymal stem cells (hMSCs). FASEB J 2008;22:1635–1648.
27. Menendez L, Yatskievych TA, Antin PB et al. Wnt signaling and a Smad pathway blockade direct the differentiation of human pluripo-tent stem cells to multipotent neural crest cells. Proc Natl Acad Sci USA 2011;108:19240–19245.
28. Lee G, Chambers SM, Tomishima MJ et al. Derivation of neural crest cells from hu-manpluripotent stemcells. Nat Protoc 2010;5: 688–701.
29. Li FD, Sexton KW, Hocking KM et al. Inti-mal thickness associated with endothelial dysfunction in human vein grafts. J Surg Res 2013;180:e55–e62.
30. Veith FJ, Gupta SK, Ascer E et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 1986;3: 104–114.
31. Poh M, Boyer M, Solan A et al. Blood vessels engineered from human cells. Lancet 2005; 365:2122–2124.
32. Syedain ZH, Tranquillo RT. TGF-b1 diminishes collagen production during long-term cyclic stretching of engineered connective tissue: Implication of decreased ERK signaling. J Bio-mech 2011;44:848–855.
33. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003;9:685–693.
34. Owens GK. Molecular control of vascular smooth muscle cell differentiation and phenotypic plasticity. Novartis Found Symp 2007;283:174–191; discussion 191–193, 238–241.
35. Williams C, Xie AW, Emani S et al. A comparison of human smooth muscle and mesen-chymal stem cells as potential cell sources for tissue-engineered vascular patches. Tissue Eng Part A 2012;18:986–998.
36. Assmann A, Delfs C, Munakata H et al. Acceleration of autologous in vivo recellularization of decellularized aortic conduits by fibronectin surface coating. Biomaterials 2013;34:6015–6026.
37. Mitchell SL, Niklason LE. Requirements for growing tissue-engineered vascular grafts. Cardiovasc Pathol 2003;12:59–64.
38. Maser RS, DePinho RA. Connecting chromosomes, crisis, and cancer. Science 2002;297: 565–569.
39. Kim S-H, Kaminker P, Campisi J. Telo-meres, aging and cancer: In search of a happy ending. Oncogene 2002;21:503–511.
40. Bielak-Zmijewska A et al. A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smoothmuscle cellsisolatedfromhumanaorta. Biogerontology 2014;15:47–64.
41. Matthews C, Gorenne I, Scott S et al. Vascular smooth muscle cells undergo telomere-based senescence in human atherosclerosis: Effects of telomerase and oxidative stress. Circ Res 2006;99:156–164.
42. Leroux-Berger M, Queguiner I, Maciel TT et al. Pathologic calcification of adult vascular smooth muscle cells differs on their crest or mesodermal embryonic origin. J Bone Miner Res 2011;26:1543–1553.
43. Wu M, Rementer C, Giachelli CM. Vascular calcification: An update on mechanisms and challenges in treatment. Calcif Tissue Int 2013; 93:365–373.